Search results
AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs
Zacks via Yahoo Finance· 1 year agoAstraZeneca PLC AZN, along with partner Merck MRK, announced that the European Commission (EC) has...
AstraZeneca's (AZN) Lynparza Gets Expanded Use Nod in Japan
Zacks via Yahoo Finance· 9 months agoAstraZeneca (AZN) gets approval for Lynparza with abiraterone and prednisolone combo in Japan to...
FDA Delays Decision on AstraZeneca (AZN), Merck's Lynparza sNDA
Zacks via Yahoo Finance· 1 year agoThe FDA extends the review period of AstraZeneca (AZN)/Merck's filing seeking label expansion for...
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Benzinga via Yahoo Finance· 2 years agoESSA Pharma Inc (NASDAQ: EPIX) announced that Johnson & Johnson's (NYSE: JNJ) Janssen is suspending...
Johnson & Johnson (JNJ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 4 months agoThe headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the...
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
Healthcare Dive via Yahoo Finance· 7 months agoBig questions hang over the California health insurer's bold experiment — having five vendors carry...
AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal
Zacks via Yahoo Finance· 1 year agoAstraZeneca AZN announced an agreement to acquire private biotech, Neogene Therapeutics to build its...
Clovis Oncology's Rubraca Hits Primary Goal In Prostate Cancer Settings
Benzinga via Yahoo Finance· 2 years agoClovis Oncology Inc (NASDAQ: CLVS) announced topline data from the Phase 3 TRITON3 trial,...
Pharma Stock Roundup: RHHBY's Alzheimer's Study Failure, EU Nod for SNY's Enjaymo
Zacks via Yahoo Finance· 2 years agoRoche's (RHHBY) late-stage Alzheimer's disease study on key pipeline candidate, gantenerumab fails....
Pharma Stock Roundup: LLY's 2023 View, MRK-MRNA Joint Cancer Vaccine Data & More
Zacks via Yahoo Finance· 1 year agoEli Lilly (LLY) gives its financial guidance for 2023. Merck (MRK) and Moderna's (MRNA) mRNA-based...